We can track the menstrual cycle in many ways. Some people simply mark the first day of bleeding on a calendar. Others record pain, sleep, mood, discharge, energy and exercise each day. Apps often promise insight and predictability. For some, that is valuable. For others, frequent questions and alerts can make the body feel like something that must constantly be measured, interpreted and improved. Four studies, published over several years, help explain why both experiences deserve attention.
When more symptoms are reported
In 2020, researchers Kate MacKrill, Katie Groom and Keith Petrie published an experimental study involving 91 participants. They randomly allocated participants to three groups: a menstrual app with symptom tracking, a simple calendar app, or no app. Menstrual and general symptoms were reported at baseline, one month and four months.
After four months, the symptom-tracking group reported an average of 1.16 more menstrual symptoms than the calendar group. The proportion in this group classified as high symptom reporters rose from 50% to 70%. Differences were found in menstrual symptom reporting, but no corresponding between-group differences were found for general symptoms.
What does that tell us? The researchers measured reported symptoms. They did not establish that tracking caused participants to develop more diseases or that pain itself became more severe. Nor could the study rule out changes in the experience of symptoms. Paying more attention to the body may make us notice sensations we would otherwise overlook. At the same time, noticing symptoms that already affect everyday life may be useful.
A small experiment over four months therefore gives us an important finding, but not a universal answer about what everyone should do.
Read research review 194 and the original study.
What do women who use the apps say?
An Australian interview study from 2026 offers another perspective. Chloe Woodland and colleagues spoke with 32 women aged 18–55 who had used a period-tracking app during the previous year. Some said that tracking gave them a better understanding of bodily signals and a sense of control. Others described inaccurate predictions, anxiety-provoking alerts and messages that made normal variation seem like signs of illness. Participants also raised concerns about privacy, paying for information and advertising.
The study describes a range of experiences, but cannot tell us how common each one is. Interviews help us understand how something is experienced. On their own, they cannot measure how many people achieve better or worse health.
Read research review 195 and the original study.
Being prepared can also be a benefit
In October 2026, researchers published an international survey of 11,910 users of the Clue app. About two in three reported concerns about their cycle or symptoms. Among those with such concerns, 96% said tracking helped them prepare for menstruation, 90% reported a better understanding of their bodies and cycle patterns, and 60% felt more confident speaking with healthcare professionals about symptoms. Only 13% of those reporting a particular main symptom said tracking helped reduce that symptom.
This points to an important distinction: the value of tracking may lie in understanding, planning and communicating, even when symptoms continue.
However, the survey had important limitations. Respondents were existing Clue users who participated voluntarily. There was no randomised control group, so researchers could not establish whether tracking caused the reported benefits. The survey was funded by Biowink, the company behind Clue. Several authors were employees or paid consultants. Potential conflicts of interest should be considered carefully, without automatically dismissing the findings.
Read research review 197 and the original study.
How common is tracking, and what do we know about its effects?
A systematic review published in 2026 combined 14 studies with 3,547 participants. Six studies contributed to an estimate of how many people used menstrual tracking apps. The pooled estimate was 61%, but there was extremely large variation across studies and researchers rated the certainty of evidence as very low. That estimate must therefore not be treated as evidence that 61% of all women use such apps. The review also highlighted issues around predictive accuracy, privacy and distress caused by inaccurate notifications.
Read research review 196 and the original study.
Knowing your body is different from optimising it
There is a difference between knowing roughly when a period will start, documenting pain before a medical appointment and feeling that every workout, commitment or work task must be adjusted to a particular cycle phase. Knowledge of our bodies can help us recognise patterns and needs. That could mean planning more rest around heavy bleeding or noticing changes in pain over time. General claims about optimising performance, diet or exercise in particular cycle phases, however, require research that tests those interventions. Personal experiences matter, but they are not the same as an effect demonstrated for everyone.
Tracking may be especially useful when symptoms recur, change or affect school, work, sleep or leisure. A simpler approach may also be worth trying if detailed tracking creates worry or takes up too much attention.
When is this a responsibility for healthcare services?
It is easy to place responsibility for understanding every bodily signal on the individual. But tracked data are only one part of the picture. People with severe pain, unusually heavy bleeding or persistent limitations in daily activities need access to assessment and treatment, whether they use an app or not. Symptoms that follow a menstrual pattern are not automatically harmless or something that must simply be endured. A symptom diary may help describe patterns, but cannot replace a clinical assessment.
What do we actually know?
We know that detailed tracking can increase the number of symptoms reported in an experiment. We also know that users describe both benefits and disadvantages, and that many report better preparation and understanding of their cycle. We know less about who achieves better overall health from tracking, who experiences more worry, and which app features offer the best balance of benefit and burden.
Perhaps the most useful question is therefore neither whether everyone should track nor whether everyone should stop. It is what we want to understand, what tracking adds and what we do with the knowledge.